Evidence to Action: Children and COVID-19

Evidence is mounting indicating that although novel coronavirus infection in infants and children generally appears to be mild or moderate, severe disease can occur, and symptoms differ from those in adults.

In this edition of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)'s Evidence to Action (E2A) webinar series, Senior HIV Technical Advisor, Dr. Lynne Mofenson explores latest research on the evolving nature of COVID-19 in children and implications for health programs, and how we can better advocate for children as this pandemic further unfolds.